01 6Tanakan
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 43
2019 Revenue in Millions : 44
Growth (%) : -4
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 40
2020 Revenue in Millions : 43
Growth (%) : 4
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2016 Revenue in Millions : 47
2015 Revenue in Millions : 55
Growth (%) : -15
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2017 Revenue in Millions : 51
2016 Revenue in Millions : 54
Growth (%) : -5
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 43
2017 Revenue in Millions : 47
Growth (%) : -9%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 40
2018 Revenue in Millions : 41
Growth (%) : -3
LOOKING FOR A SUPPLIER?
